chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; fevers Tmax 103; weakness; loss of appetite; This is a spontaneous report from a contactable other health care professional.   A patient of unspecified age and gender received BNT162B2(PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 10Mar2021 as dose 2, single for covid-19 immunization.  The patient medical history was not reported. Concomitant medication included ibuprofen (ADVIL [IBUPROFEN]).  Patient historical vaccine included BNT162B2(PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 19Feb2021 as dose 1, single for covid-19 immunization and experienced arm soreness and lower back pain. The patient experienced sore arm after vaccination. Patient had fevers Tmax 103, weakness, and loss of appetite starting on 17Mar2021 and had no vomiting or diarrhea. Patient was  feeling much better 21Mar2021. No further fevers but now taking Advil. The patient underwent lab tests and procedures which included body temperature: 103 (units unspecified). The outcome of the event sore arm, weakness and loss of appetite was recovering, outcome of fever was resolved on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Severe headache, 105.6 fever, chills, neck pain, joints and body ache eyesight blurry, semi conscious, lethargic.
Patient received vaccine today came back to clinic with hard firm area of the (R) alteral proximal arm about 3-4 cm with swelling.
Day one - Mild headache, sore arm at injection site, chills Day two (today) - Sore arm remains, new  mild joint pain in both knees, headache gone and chills gone.
Developed a cough and was really fatigued; Took a home COVID-19 test and it was positive; Called doctor and was prescribed PAXLOVID, but had an allergic reaction; Rested and took extra vitamins. Didn't retest for COVID-19; Doctor believes she may have Long COVID.
Information has been received from a licensed practical nurse concerning a female who on 07-JAN-2008 was vaccinated with her first dose of 0.5 ml Gardasil intramuscularly.  The patient fainted after she was given the vaccine.  No other information was available.  As of 07-JAN-2008 the patient recovered from her experience.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2008. Information has been received from a licensed practical nurse concerning a 19 year old white female who on 07-JAN-2008 was vaccinated with her first dose of GARDASIL (Lot #655439/1257U) intramuscularly in the left arm at 10:00 am. There was no concomitant medication. The patient fainted after she was given the vaccine. No other information was available. As of 07-JAN-2008 the patient recovered from her experience. Follow up information has been received from the licensed practical nurse on 28-FEB-2008. It was reported that on 07-JAN-2008 at 10:00 am the patient fainted and hit her head and hurt  her neck. The patient was evaluated and neck and skull x-rays were performed. Both skull and cervical spine x-rays were negative. The patient was watched for about an hour and released to her mother. No further information is expected.
Info recvd from consumer, 16 mon old rec'd vax & devel a mild rash on face & chest.
Case number PHHY2017US024206, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 663079) website on 23 Jan 2017. This report refers to a 14 years old male patient. Past medical history was not reported. Current condition included as asthma. Concomitant medication was not reported. The patient was vaccinated with INN (manufacturer and batch number: not reported) into left arm on 31 Oct 2016. The patient also vaccinated with human papilloma virus vaccine (other manufacturer, batch number: not reported) into right arm (reported as HPV) on 31 Oct 2016. On the same day after vaccination, the patient experienced nausea, vomiting, exhaustion and fever. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
had a shot got shingles / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had the shingles had a shot got shingles again. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Adverse events included: Fever, severe fatigue, joint pain in both hands, hips, and knees, swelling in hands, chills, and muscle pain throughout my body.
Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: Patient has developed numbness and tingling to extremity which continues to persist.
other zoster-related conditions; Developed painful shingles, itching, blisters/shingles and other zoster-related conditions; This spontaneous report as received from a physician and a pharmacist refers to a 69-year-old female patient with allergy to meloxicam and tetanus. The patient was enrolled in the Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine strain and a completed form was received on 10-SEP-2012. The patient's medical history included allergic rhinitis and art (as reported). The patient had no recent exposure to chickenpox and shingles.  On 28-AUG-2012 (also reported as 31-AUG-2012) the patient was vaccinated subcutaneously in the left arm with 0.65 ml dose of zoster vaccine live (ZOSTAVAX) (lot number 671901/0421AE, expiration date 21-MAR-2013). Concomitant medications included hydrochlorothiazide, fluticasone furoate (VERAMYST), estrogens, conjugated, methyltestosterone, cyanocobalamin (reported as B12) and ranitidine hydrochloride (ZANTAC). The pharmacist reported that on an unknown date in 2012 the patient developed painful shingles after receiving zoster vaccine live (ZOSTAVAX). She developed rash under her arms, breasts, chest and back, itching and blisters identified as herpes zoster. No treatment was given for the event. Medical attention was sought for the event, the patient called the pharmacist. On 07-SEP-2012 a nasal swab specimen was collected and was sent to the laboratory on 10-SEP-2012 for Varicella Zoster Virus (VZV) Strain Identification Polymerase Chain Reaction (PCR). Results were pending at the time of this report. The outcome was reported as not recovered at the time of this report.  Follow up (FU) information was recieved on 15-OCT-2012. On 11-SEP-2012 final PCR specimen results identified the presence of VZV wild type strain.  Additional information has been requested.  FU information was received on 07-FEB-2022 from a lawyer regarding the case in litigation. It was reported that on or about 31-AUG-2012, the patient (pt) was vaccinated by a pharmacist at a pharmacy with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and zoster/related conditions. Subsequently, on an unknown date, the pt was treated by a physician for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: shingles and other zoster-related conditions. The outcome of the events was not provided (hence, the outcome remained not recovered/not resolved as previously reported for the event of shingles, and was considered unknown for the newly added event of other zoster-related conditions). The lawyer considered both events to be related to zoster vaccine live (ZOSTAVAX).  FU information has been received on 16-FEB-2022 via pharmacy records. It was reported that zoster vaccine live (ZOSTAVAX) injection subcutaneous (SQ) was dispensed (sold) to the pt on 31-AUG-2012.
It was reported that a female pt received a TD Adult on 3/30/00. Sometime, post vax, the pt developed a swollen, red, hard nodule at the injection site. Additional information is being requested. From correspondence received on 5/4/00, additional pt, vaccine, responsible physician and vaccine administrator information was provided.
a used vial of janssen vaccine was placed back in manufacturer box after withdrawing 2 doses instead of being placed in yellow vial labeled with BUD information. next day vial was pulled from manufacturer box and 3 vaccines were given before discovering vaccine was expired.
12:52 pm - face/mouth area feels itchy; heart palpitations occur; 12:56 pm - face starts getting blotchy with hive-type mark near mouth; 1 p.m. - body starts feeling itchy allover; Around 1:20 pm the mouth hive seems to have gone away and the itchy is less bothersome. By the afternoon, everything seems to have subsided. Arm is very sore the next morning.
Quarter size lump in R/thigh w/redness(HIB site). Mother says lump did not appear until 11/19/99. Instructed to apply cool compresses & give Tylenol.
Swollen limp nods on left side of neck.; Immediately my arm ached where shot was given; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 66-year-old non-pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 17Feb2021 at 08:00 (Lot Number: EN5318) as dose 2, single (at the age of 66-year-old) for COVID-19 immunisation. The patient was not pregnant at the time of vaccination.Medical history included hypertension and thyroid from an unknown date and unknown if ongoing. The patient did not have COVID prior vaccination. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), lisinopril, glucosamine and multi vitamin (all received within two weeks) all taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced Known allergies. Historical vaccine included first dose of bnt162b2 on 24Jan2021 at 11.00 (Batch/lot number: Unknown, administered in right arm) (at the age of 65-year-old) for COVID-19 immunisation. The patient did not receive any other vaccine in four weeks. On 19Feb2021 at 08.00, the patient experienced swollen limp nods on left side of neck, Same side where patient was given the second vaccination. Appeared exactly 2 days later. Immediately patient arm ached where shot was given and was still achy two days later but not as much. The patient not tested for COVID post vaccination. No treatment received for events.The outcome of events reported as not recovered.  Follow-up attempts completed. No further information expected.
Patient came in for second dose of Pfizer COVID-19 vaccine which was completed on 09/15/21. The issue is that patient had received first dose 08/31/21 outside making patient too early for their second dose. Patient had no reaction to receiving second dose, but it was too early unfortunately and was not caught until after vaccination.
Information has been received from a pharmacist concerning a female in her 70's with a history of knee surgery who was vaccinated subcutaneously with Zostavax (Oka/Merck).  Twenty-one days post injection, the patient developed a rash that started on her leg, but then formed all over her body.  The rash resembled chicken pox.  The rash resolved within 4 days, it had dried up.  Additional information is not expected.
Pt c/o clogged ears, which happened last time she passed out during blood draw. Denies dizziness, denies LOC. Pt placed on back on floor with feet on chair in pod while awaiting stretcher arrival. Pt able to stand and ambulate to stretcher, transported to med obs #1. Pt reports resolution of symptoms upon arrival to med obs. VSS. No s/s of distress noted. Requesting to d/c to home. Pt escorted to exit with staff and significant other. VS are as follows: 1640: BP 138/90, HR 97, RR 17, O2 sat 99% on RA
Fever; sore arm; hot site of injection; flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of fever in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th September 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 20th September 2019, 1 days after receiving Shingrix, the patient experienced fever, pain in arm, injection site warmth and influenza-like symptoms. The patient was treated with ibuprofen (Advil). On 23rd September 2019, the outcome of the pain in arm, injection site warmth and influenza-like symptoms were recovered/resolved. On an unknown date, the outcome of the fever was not recovered/not resolved.   The reporter considered the fever, pain in arm, injection site warmth and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right deltoid. The patient had fever of 103.9 degree F. The patient had Advil as a treatment medication for fever, but it keeps popping up again. The patient stated that, all symptoms were resolved except fever. On the day of reporting, the patient had routine check up, but forgot to have temperature taken. All other test were normal. The patient consented to follow up.      Lab Comments: Unspecified laboratory test were normal.
Chills fever up to 100.2  & very tired, all lasted only about  5 hours, fever peaked @100.2  & then it was over.
Bell's Palsy is reported in a pt who recvd flu vax; 24 hrs p/vax, pt devel bell's palsy, which has not entirely cleared p/4 wks, but is much improved; Pt has recvd many flu vax in the past w/o sequelae & has never had bell's palsy;
Started with light-headedness within 1 hour, decreased tiredness next day, above continued, plus got headache (severe) by 3rd day, blood pressure and pulse became elevated.  Rash started on arms and chest, headache severe, paleness 4th day-red, blotchy rash all over (except legs) and blood pressure and pulse continued to increase and low fever (on and off).
Vaccine 1: tongue felt thick, then the left side of my face lost some sensitivity. I was pinching my cheeks because I noticed a weakness in the left side of my face.   Vaccine 2: It has been 3 weeks and my right arm from the injection site is weak and sore -- only when my arm is lifted can I feel where the vaccine was injected and there is loss of strength in that area/soreness.
Information has been received from a health professional concerning an 18 month old to 2 year old female with no past medical history and no allergies who was vaccinated with measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  There was no concomitant medication.  Subsequently, two weeks later she experienced measles.  Unspecified medical attention was sought.  No product quality complaint involved.  No further information is requested.
This spontaneous report as received from a consumer refers to her 1 year old daughter. On an unknown date in August 2014, the patient was vaccinated with one shot of M-M-R II (lot# and strength unknown), 1 shot, injection for vaccine. On the same day, the patient also received a shot of TDAP (unspecified)  (lot #, strength, dosage and route unknown). The same day the M-M-R II was administered, the patient had a severe reaction . The patient's "equilibrium (reported as equillbrim) was off" and was constantly crying uncontrollably, ran a fever of 103 for 5 days, was taken to the emergency room (ER) twice, broke out in a rash and had inflamed lymph nodes all over her body. She did not want to walk, wasn't sleeping or eating. And according to an unspecified HCP, the patient might have caught a cold as well. The reporter stated these symptoms occurred all through August 2014. Treatment of being given fluids and an unspecified steroid had been give and blood work had been performed on unspecified date (result unspecified). The outcome of the events was unknown. Additional information has been requested.
Information has been received from a healthcare worker concerning a 21 year old female with no known drug allergies, who on 14-AUG-2007 at 11:30 a.m., was vaccinated IM in the left deltoid with the first dose 0.5 ml, of HPV rL1 6 11 16 18 VLP vaccine (yeast) (lot #658222/0827U). Concomitant therapy included unspecified birth control medication. On 14-AUG_2007 (previously reported as 15-AUG-2007) the patient developed an egg shaped swelling at the injection site that lasted 1 week and dizziness that lasted for 2 days after her first immunization with HPV rL1 6 11 16 18 VLP vaccine (yeast). There was no illness reported at the time of vaccination. The patient mentioned the adverse event at the next office visit. No laboratory/diagnostic tests were performed. Subsequently, the patient recovered from an egg shaped swelling at the injection site and dizziness. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2007. Additional information is not expected.
Within minutes of receiving Flublok, the patient became clammy, felt nauseous, and started dry heaving, Cool compresses were applied to back and neck, fan was turned on, cool water was given to drink. The patient requested to lie back so the chair was then put in a recline position. Soon after, his eyes rolled back in his head and he became unresponsive, slight jerking  (seizure like) movements were observed for approximately 30 seconds. When he came to, he e said his arms felt heavy, and numb and tingly. He also experience slight bladder incontinence. After 15 minutes or so, the feeling in arms returned to normal. It's worth noting that the patient experienced a similar reaction following the COVID (J&J) vaccine.
Tested positive Covid-19 virus; Tested positive Covid-19 virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group for a Pfizer sponsored program (159558). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Apr2021 (Lot number: EP7533) at the age of 52 years as dose 2, single and administered in arm left, administration date 01Apr2021 (Lot number: EP7533) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 26Dec2021, outcome "recovered" (03Jan2022) and all described as "Tested positive Covid-19 virus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2022) negative; (26Dec2021) positive. Patient tested positive for the Covid virus on the Day after Christmas 26Dec2021, quarantined then for 10 days, tested negative on 03Jan2022, wants to know when is the soonest time to get the booster. It was unknown if other products were administered or not. Investigation assessment was reported as no.  No follow-up attempts are possible. No further information is expected.
"I received the Pfizer Covid vaccine Wed afternoon around 4pm. Thursday morning around 9:30 I started with severe pain in my left leg. The pain worsened through the day and my leg began swelling. No other symptoms at all. This morning my leg was twice the size of my right leg so I went to the ER. I live in so I'm at ED. I have a massive blood clot running the the length of my leg - from my thigh to my ankle. I'm very lucky I got here so fast! I?m a very healthy 49 year old with no history of DVT or blood clots so they dug further to find out why. A cat scan showed I have a congenital condition called May Thurner Syndrome. I?m so relieved to have an answer and it?s fixable! The vascular doctors are not 100% convinced that?s not all that was going on as I was born with the syndrome and I?ve gone this long without a clot. So they are doing lots of labs to see if anything else shows up. This is where we are at. I?m being admitted to take care of the clot."
This is a spontaneous report from a contactable consumer (the mother of the patient). A 20-years-old female patient received TRUMENBA, single dose in the arm via unspecified route of administration on unknown date. The patient on 13Mar2015 experienced pain in her arm and chills. The patient recovered from the events on 16Mar2015. No follow up attempts possible. No further information expected.
C/o sharp pain in left side of head that migrated down her arm & across her chest. She was shaking all over & felt "warm all of a sudden" she was Extremely anxious. Code Green called when H2O & trying to calm her down didn't work. paramedics arrived to assess.
Patient reported having warm and itchy at sight of injection starting after lunch the day after the injection through the Saturday after her injection.  On Sunday, she had breast pain on the opposite side that she received the injection.  So she reported breast pain on her right side.
Pt. developed a rash on right thigh at the injection site. PCP diagnosed as cellulitis. Treated with antibiotics. Rash resolved 4/15/19
I was 17 weeks and 2 days pregnant (from an IVF cycle with a donor egg) the day I received the vaccine. My baby stopped growing the same day I received the vaccine - (subsequent ultrasounds showed no growth beyond 17 weeks and 2 days. The baby's heartbeat stopped sometime around one week after the vaccine. I had to get induced on Saturday August 7th and delivered the baby on Sunday August 8th. The reason listed on the autopsy is fetal demise.
Pain from injection. Lasted 2 days. Bad dreams 12 hours after injection.  Very low energy 30 hours after injection with a metallic taste in my mouth, Aches and pains, diarrhea,  nausea, racing heart, confusion, exhaustion, 5 days after injection energy is better. All other symptoms are slowly subsiding.
Bruising at the injection site; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruising at the injection site) and VACCINATION SITE PAIN (Pain at the injection site) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruising at the injection site) and VACCINATION SITE PAIN (Pain at the injection site). On 16-Mar-2021, VACCINATION SITE BRUISING (Bruising at the injection site) and VACCINATION SITE PAIN (Pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was provided.